Biofield To Submit Revamped PMA For Breast Cancer Diagnosis System
This article was originally published in The Gray Sheet
Executive Summary
Biofield is planning to make a second attempt at securing FDA approval for its Biofield Diagnostic Device following the completion of an upcoming clinical trial of the non-invasive tool to evaluate its use as an aid in breast cancer detection.